Magnisense is a develops emergency diagnostic tests for cardiovascular diseases
Magnisense conçoit, développe et commercialise des tests de diagnostic d'urgence pour les maladies cardio-vasculaires à partir de sa technologie MIAtek® et de son instrument de diagnostic propriétaires
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Oct 26, 2018 | Series Unknown | €5M | 2 | — | — | Detail |
Nov 27, 2015 | Series Unknown | €5.50M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Minv | — | Series Unknown |
Concorde Capital | — | Series Unknown |